Proteomics

Dataset Information

0

Conformational dynamics underlying Atypical Chemokine Receptor 3 activation


ABSTRACT: Here we used Hydrogen/Deuterium exchange mass spectrometry (HDX-MS) to examine the binding mode and mechanism of action of various small-molecule ACKR3 ligands of different efficacy for β-arrestin recruitment. Our results show that activation or inhibition of ACKR3 is largely governed by intracellular conformational changes of helix 6, intracellular loop 2 and helix 7, while the DRY motif becomes protected during both processes. Moreover, HDX-MS identifies the binding sites and the allosteric modulation of ACKR3 upon β-arrestin 1 binding.

INSTRUMENT(S): nanoACQUITY UPLC with HDX Technology

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Functional Proteomics Platform FPP  

LAB HEAD: Cherine Bechara

PROVIDER: PXD044103 | Pride | 2024-07-16

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
ACKR3_sequence.txt Txt
Dataset1_arrestin-Dataset2_15485_25550.tar.bz2 Other
Dataset1_small-ligands.tar.bz2 Other
Dataset2_16840.tar.bz2 Other
Dataset2_arrestin.tar.bz2 Other
Items per page:
1 - 5 of 7
altmetric image

Publications

Conformational dynamics underlying atypical chemokine receptor 3 activation.

Otun Omolade O   Aljamous Christelle C   Del Nero Elise E   Arimont-Segura Marta M   Bosma Reggie R   Zarzycka Barbara B   Girbau Tristan T   Leyrat Cédric C   de Graaf Chris C   Leurs Rob R   Durroux Thierry T   Granier Sébastien S   Cong Xiaojing X   Bechara Cherine C  

Proceedings of the National Academy of Sciences of the United States of America 20240715 30


Atypical Chemokine Receptor 3 (ACKR3) belongs to the G protein-coupled receptor family but it does not signal through G proteins. The structural properties that govern the functional selectivity and the conformational dynamics of ACKR3 activation are poorly understood. Here, we combined hydrogen/deuterium exchange mass spectrometry, site-directed mutagenesis, and molecular dynamics simulations to examine the binding mode and mechanism of action of ACKR3 ligands of different efficacies. Our resul  ...[more]

Similar Datasets

2020-04-16 | PXD018028 | Pride
2024-08-30 | PXD051297 | Pride
2021-11-03 | PXD027043 | Pride
2024-07-03 | PXD048638 | Pride
2024-07-15 | PXD049391 | Pride
2023-12-06 | PXD046965 | Pride
2023-10-24 | PXD041067 | Pride
2022-02-22 | PXD029402 | Pride
2024-07-03 | PXD048642 | Pride
2020-11-11 | PXD018910 | Pride